Skip to Content

Vanguard Long-Term Corporate Bd Idx Adm VLTCX

Medalist Rating as of | See Vanguard Investment Hub
  • NAV / 1-Day Return 20.25  /  +0.80 %
  • Total Assets 9.9 Bil
  • Adj. Expense Ratio
    0.070%
  • Expense Ratio 0.070%
  • Distribution Fee Level Low
  • Share Class Type Institutional
  • Category Long-Term Bond
  • Credit Quality / Interest Rate Sensitivity Medium/Extensive
  • Min. Initial Investment 3,000
  • Status Open
  • TTM Yield 5.04%
  • Effective Duration 12.90 years

USD | NAV as of Jul 02, 2024 | 1-Day Return as of Jul 02, 2024, 10:17 PM GMT+0

Morningstar’s Analysis VLTCX

Will VLTCX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Diversified long-term corporate bonds at a low cost.

Director Bryan Armour

Bryan Armour

Director

Summary

We have qualitatively reviewed this strategy and reaffirmed its Above Average People and Above Average Process ratings. Vanguard Long-Term Corporate Bond ETF boasts a well-diversified, market-value-weighted portfolio and a rock-bottom fee. It’s a solid option for long-term U.S. investment-grade corporate bonds. The following text is from Feb. 27, 2023.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings VLTCX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 2.7
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Anheuser-Busch Companies LLC / Anheuser-Busch InBev Worldwide Inc

0.39 37.8 Mil
Corporate

CVS Health Corp

0.32 30.8 Mil
Corporate

WarnerMedia Holdings Inc.

0.27 26.0 Mil
Corporate

Pfizer Investment Enterprises Pte Ltd.

0.26 25.4 Mil
Corporate

Goldman Sachs Group, Inc.

0.26 25.3 Mil
Corporate

AT&T Inc

0.25 24.6 Mil
Corporate

Anheuser-Busch Companies LLC / Anheuser-Busch InBev Worldwide Inc

0.25 24.5 Mil
Corporate

CVS Health Corp

0.25 24.0 Mil
Corporate

AT&T Inc

0.24 23.4 Mil
Corporate

AbbVie Inc.

0.24 22.9 Mil
Corporate